The Scientist

» FDA, developmental biology and microbiology

Most Recent

image: Enzyme Improves CRISPR

Enzyme Improves CRISPR

By | April 1, 2015

A smaller Cas9 protein enables in vivo genome engineering via viral vectors.

0 Comments

image: Contributors

Contributors

By | April 1, 2015

Meet some of the people featured in the April 2015 issue of The Scientist.

0 Comments

image: Manipulative Microbiomes

Manipulative Microbiomes

By | April 1, 2015

Gut bacteria control tumor growth via the mammalian immune system.

3 Comments

image: From Many, One

From Many, One

By | April 1, 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?

4 Comments

image: Soil Bacteria Live on Wine Grapes

Soil Bacteria Live on Wine Grapes

By | March 25, 2015

The earthiness of Merlot may have to do with grapevine-dwelling microbiota.

2 Comments

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: FDA Deems GM Apples, Potatoes Safe

FDA Deems GM Apples, Potatoes Safe

By | March 23, 2015

Genetically modified, non-browning apples and bruise-resistant potatoes are safe, the US Food and Drug Administration says.

0 Comments

image: Quorum-Sensing Molecule Modifies Gut Microbiota

Quorum-Sensing Molecule Modifies Gut Microbiota

By | March 19, 2015

Increasing the abundance of a chemical some microbes use to communicate with one another can help reinstate beneficial bacterial populations in the guts of antibiotic-treated mice. 

1 Comment

image: Sewage Bacteria Linked to Obesity

Sewage Bacteria Linked to Obesity

By | March 10, 2015

Microbes identified in a city’s sewage treatment plants correlate with the population’s obesity rate, a study shows.

1 Comment

image: FDA OKs First Biosimilar

FDA OKs First Biosimilar

By | March 6, 2015

The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.

2 Comments

Popular Now

  1. Optimism for Key Deer After Hurricane Irma
  2. Do Microbes Trigger Alzheimer’s Disease?
  3. Decoding the Tripping Brain
  4. Tattoo Ink Nanoparticles Persist in Lymph Nodes
    The Nutshell Tattoo Ink Nanoparticles Persist in Lymph Nodes

    Analysis of the bodies of deceased individuals can’t determine what effect these tattoo remnants have on lymph function, but researchers suggest dirty needles aren’t the only risk of the age-old practice.

AAAS